1,2-Disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for treating diseases such as hyperlipidemia or arteriosclerosis

摘要

The present invention provides a compound of formula (I): wherein the variants R1, R2, R3, R4, R6, R7 are as defined herein, and wherein said compound is an inhibitor of CETP, and thus can be employed for the treatment of a disorder or disease mediated by CETP or responsive to the inhibition of CETP.